Company Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra 11:35:46 2024-04-26 am EDT 5-day change 1st Jan Change
9.235 EUR +0.82% Intraday chart for Evotec SE -30.35% -56.60%

Business Summary

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Number of employees: 5,061

Sales per Business

EUR in Million2022Weight2023Weight Delta
EVT Execute
65.8 %
547 72.8 % 515 65.8 % -5.89%
EVT Innovate
34.2 %
205 27.2 % 267 34.2 % +30.36%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
59.5 %
418 55.7 % 459 59.5 % +9.83%
Rest of the World
12.3 %
127 16.9 % 95 12.3 % -24.91%
United Kingdom
11.2 %
115 15.3 % 86 11.2 % -25.06%
Switzerland
8.4 %
-- 65 8.4 % -
Germany
4.4 %
59 7.8 % 34 4.4 % -42.04%
France
4.1 %
32 4.3 % 32 4.1 % -0.83%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 19-06-18
Director of Finance/CFO 51 23-02-06
Chief Operating Officer 54 12-04-30
Chief Tech/Sci/R&D Officer 60 10-08-31
Public Communications Contact - -
Investor Relations Contact - -
Corporate Officer/Principal 51 22-04-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 61 19-06-18
Director/Board Member 56 19-06-18
Chairman 63 14-06-16
Director/Board Member 63 15-06-08
Director/Board Member 41 22-06-21
Director/Board Member 62 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 177,542,097 160,931,634 ( 90.64 %) 249,915 ( 0.1408 %) 90.64 %

Shareholders

NameEquities%Valuation
Novo Holdings A/S (Investment Company)
8.410 %
14,931,858 8.410 % 233 M €
Mubadala Investment Co. (Investment Company)
6.467 %
11,481,503 6.467 % 179 M €
T. Rowe Price International Ltd.
3.110 %
5,521,559 3.110 % 86 M €
2,904,146 1.636 % 45 M €
1,514,826 0.8532 % 24 M €
LBBW Asset Management Investmentgesellschaft mbH
0.7800 %
1,384,900 0.7800 % 22 M €
Fleming Family & Partners Capital Management LLP (Austria)
0.6308 %
1,120,000 0.6308 % 18 M €
Swedbank Robur Fonder AB
0.5599 %
994,000 0.5599 % 16 M €
Carmignac Gestion Luxembourg SA (UK)
0.5593 %
993,007 0.5593 % 16 M €
Lupus alpha Asset Management AG
0.5424 %
963,000 0.5424 % 15 M €
NameEquities%Valuation
Mubadala Investment Co. (Investment Company)
5.179 %
4,597,701 5.179 % 36 M €
Federated Global Investment Management Corp.
0.6499 %
576,933 0.6499 % 5 M €
Banque BPP SA
0.2704 %
240,000 0.2704 % 2 M €
Millennium Management LLC
0.0973 %
86,385 0.0973 % 676 395 €
Optiver Holding BV
0.0910 %
80,810 0.0910 % 632 742 €
DCF Advisers LLC
0.0538 %
47,797 0.0538 % 374 251 €
Morgan Stanley Investment Management, Inc.
0.0492 %
43,707 0.0492 % 342 226 €
Pioneer Investments Austria GmbH
0.0475 %
42,168 0.0475 % 330 175 €
Cetera Investment Advisers LLC
0.0289 %
25,638 0.0289 % 200 746 €
Aperio Group LLC
0.0137 %
12,178 0.0137 % 95 354 €

Holdings

NameEquities%Valuation
14,035,200 11.86% 80,281,344 $

Company contact information

Evotec SE

Manfred Eigen Campus Essener Bogen 7

22419, Hamburg

+49 40 560 81 0

http://evotec.com
address Evotec SE(EVT)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Pharmaceuticals: Major
Miscellaneous Commercial Services
Miscellaneous Commercial Services